Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism.
about
Dehydroepiandrosterone for women in the peri- or postmenopausal phaseDehydroepiandrosterone for menopausal womenRetinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review)p27(Kip1) deficiency promotes prostate carcinogenesis but does not affect the efficacy of retinoids in suppressing the neoplastic process.DHEA metabolites activate estrogen receptors alpha and betaDehydroepiandrosterone, androgens and the mammary gland.High Expression of Cyclin D1 and p21 in N-Nitroso-N-Methylurea-Induced Breast Cancer in Wistar Albino Female Rats.Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone.Multiple B-vitamin inadequacy amplifies alterations induced by folate depletion in p53 expression and its downstream effector MDM2Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.Dehydroepiandrosterone reduces preadipocyte proliferation via androgen receptor.Stimulation of Sigma-1 receptor by dehydroepiandrosterone ameliorates hypertension-induced kidney hypertrophy in ovariectomized rats.Dehydroepiandrosterone augments sensitivity to gamma-ray irradiation in human H4 neuroglioma cells through down-regulation of Akt signaling.
P2860
Q24186536-8C5B40DB-3617-4CF4-9083-9C568F4AF0C6Q24197629-A1FFFAB2-87B1-4DD8-86C5-48910F840918Q28081010-B2057F6E-05A6-4AA3-BB7E-FF982785CF17Q33713330-5D50C446-B21E-4A5B-9DD8-04744FF26DA5Q34309799-D5C59035-23D5-4138-942B-B785C6C7535EQ36533630-289535D0-47E5-440D-B1C2-B27221D4ECDAQ36645108-D72C6077-6D5B-41A6-8FC8-954CC72AA733Q36808074-31E16CBF-80AB-492E-8D91-A0419DC67508Q37393968-3AFA23E9-C9E8-4038-BBB9-8B0F813A2A4DQ39809126-6F8434E4-0A34-49DB-A55A-57FB21E3A61BQ42801114-74E01B29-D4B3-4DFA-9143-2021E90CD685Q43093122-1F379055-A683-4878-AB86-76FD8A5DB882Q46230312-3B7CAAC4-DF2D-4B1A-9560-11FB545653C2
P2860
Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism
@nl
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism.
@ast
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism.
@en
type
label
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism
@nl
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism.
@ast
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism.
@en
prefLabel
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism
@nl
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism.
@ast
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism.
@en
P2093
P2860
P356
P1476
Dehydroepiandrosterone inhibit ...... but p53-independent mechanism.
@en
P2093
Albert Green
Anne Shilkaitis
Konstantin Christov
Ronald Lubet
Vernon Steele
P2860
P2888
P304
P356
10.1186/BCR1350
P407
P577
2005-11-16T00:00:00Z
P5875
P6179
1042018036